GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.
Company address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, 400030
How to Buy GlaxoSmithKline Pharmaceuticals Ltd Stock?
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for GlaxoSmithKline Pharmaceuticals Ltd or scroll over to GlaxoSmithKline Pharmaceuticals Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of GlaxoSmithKline Pharmaceuticals Ltd?
The share price of GlaxoSmithKline Pharmaceuticals Ltd stocks is ₹2,272.00 as on 20/12/2024
What is the Market Cap of GlaxoSmithKline Pharmaceuticals Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of GlaxoSmithKline Pharmaceuticals Ltd stock is ₹38,489.1 Cr on 20/12/2024.
In which sector / industry does GlaxoSmithKline Pharmaceuticals Ltd operate?
GlaxoSmithKline Pharmaceuticals Ltd operates in Healthcare / Drug Manufacturers - General.
What was the revenue of GlaxoSmithKline Pharmaceuticals Ltd?
The revenue of GlaxoSmithKline Pharmaceuticals Ltd as of 2023 was ₹3,441.8 Cr
What is the PE ratio of GlaxoSmithKline Pharmaceuticals Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of GlaxoSmithKline Pharmaceuticals Ltd is
57.01 as on 20/12/2024.
What is the 52 week high price of GlaxoSmithKline Pharmaceuticals Ltd?
The 52 week high of GlaxoSmithKline Pharmaceuticals Ltd stock is ₹3,087.95.
What is the 52 week low price of GlaxoSmithKline Pharmaceuticals Ltd?
The 52 week low of GlaxoSmithKline Pharmaceuticals Ltd stock is ₹1,668.20.
Can fractional shares of GlaxoSmithKline Pharmaceuticals Ltd be purchased?
No, you cannot buy fractional shares of GlaxoSmithKline Pharmaceuticals Ltd, or any listed Indian company as of now.